China Medicine Valuation
| CHME Stock | USD 0.0001 0.00 0.00% |
China Medicine seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of China Medicine from analyzing the firm fundamentals such as Current Valuation of 2 M, profit margin of 0.09 %, and Return On Equity of 0.0663 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that China Medicine's price fluctuation is out of control at this time. Calculation of the real value of China Medicine is based on 3 months time horizon. Increasing China Medicine's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the China pink sheet is determined by what a typical buyer is willing to pay for full or partial control of China Medicine. Since China Medicine is currently traded on the exchange, buyers and sellers on that exchange determine the market value of China Pink Sheet. However, China Medicine's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 9.6E-5 | Hype 9.5E-5 |
The real value of China Pink Sheet, also known as its intrinsic value, is the underlying worth of China Medicine Company, which is reflected in its stock price. It is based on China Medicine's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of China Medicine's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of China Medicine helps investors to forecast how China pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of China Medicine more accurately as focusing exclusively on China Medicine's fundamentals will not take into account other important factors: China Medicine Total Value Analysis
China Medicine is currently expected to have valuation of 2 M with market capitalization of 284.54 K, debt of 4.05 M, and cash on hands of 7.85 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the China Medicine fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2 M | 284.54 K | 4.05 M | 7.85 M |
China Medicine Investor Information
The company has price-to-book (P/B) ratio of 0.07. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Medicine recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from China Medicine's historical financial statements, China Medicine is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.China Medicine Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. China Medicine has an asset utilization ratio of 96.87 percent. This indicates that the Company is making $0.97 for each dollar of assets. An increasing asset utilization means that China Medicine is more efficient with each dollar of assets it utilizes for everyday operations.China Medicine Profitability Analysis
The company reported the previous year's revenue of 64.75 M. Net Income was 1.72 M with profit before overhead, payroll, taxes, and interest of 18.98 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates China Medicine's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in China Medicine and how it compares across the competition.
About China Medicine Valuation
The pink sheet valuation mechanism determines China Medicine's current worth on a weekly basis. Our valuation model uses a comparative analysis of China Medicine. We calculate exposure to China Medicine's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of China Medicine's related companies.China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China. CHINA MEDICINE operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 281 people.
8 Steps to conduct China Medicine's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates China Medicine's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct China Medicine's valuation analysis, follow these 8 steps:- Gather financial information: Obtain China Medicine's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine China Medicine's revenue streams: Identify China Medicine's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research China Medicine's industry and market trends, including the size of the market, growth rate, and competition.
- Establish China Medicine's growth potential: Evaluate China Medicine's management, business model, and growth potential.
- Determine China Medicine's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate China Medicine's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
China Medicine Growth Indicators
Investing in growth stocks can be very risky. If the company such as China Medicine does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Quarterly Earnings Growth Y O Y | -0.732 | |
| Retained Earnings | 27.2 M |
Complementary Tools for China Pink Sheet analysis
When running China Medicine's price analysis, check to measure China Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medicine is operating at the current time. Most of China Medicine's value examination focuses on studying past and present price action to predict the probability of China Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medicine's price. Additionally, you may evaluate how the addition of China Medicine to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |